Midecamycin
Midecamycin is a macrolide antibiotic used in the treatment of various bacterial infections. It is derived from the bacterium Streptomyces mycarofaciens. Midecamycin is particularly effective against Gram-positive bacteria and some Gram-negative bacteria.
Mechanism of Action
Midecamycin works by inhibiting bacterial protein synthesis. It binds to the 50S subunit of the bacterial ribosome, thereby preventing the translocation of peptides during translation. This action effectively halts bacterial growth and replication.
Pharmacokinetics
Midecamycin is administered orally and is well-absorbed from the gastrointestinal tract. It is metabolized in the liver and excreted primarily in the bile and, to a lesser extent, in the urine.
Clinical Uses
Midecamycin is used to treat a variety of infections, including:
- Respiratory tract infections
- Skin and soft tissue infections
- Urinary tract infections
- Gastrointestinal infections
Side Effects
Common side effects of midecamycin include:
- Gastrointestinal disturbances such as nausea, vomiting, and diarrhea
- Allergic reactions like rash and pruritus
- Hepatotoxicity in rare cases
Contraindications
Midecamycin should not be used in patients with:
- Known hypersensitivity to macrolide antibiotics
- Severe liver disease
Drug Interactions
Midecamycin can interact with other medications, including:
- Warfarin - increased risk of bleeding
- Theophylline - increased serum levels of theophylline
- Carbamazepine - increased serum levels of carbamazepine
History
Midecamycin was first isolated and identified in the 1970s. It has since been used in various countries for the treatment of bacterial infections, particularly in cases where patients are allergic to penicillin.
See Also
References
External Links
Midecamycin | |
---|---|
[[File:|frameless|220px|alt=|]] | |
INN | |
Drug class | |
Routes of administration | |
Pregnancy category | |
Bioavailability | |
Metabolism | |
Elimination half-life | |
Excretion | |
Legal status | |
CAS Number | |
PubChem | |
DrugBank | |
ChemSpider | |
KEGG |
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD